DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
« Back to Dashboard
Maravirocis the generic ingredient in one branded drug marketed by Viiv Hlthcare and is included in two NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.
Maraviroc has ninety-six patent family members in fifty-five countries.
There are two drug master file entries for maraviroc. One supplier is listed for this compound. There are two tentative approvals for this compound.
Summary for maraviroc
|Drug Master File Entries:||2|
|Finished Product Suppliers / Packagers:||1|
|Raw Ingredient (Bulk) Api Vendors:||82|
|Formulation / Manufacturing:||see details|
|What excipients (inactive ingredients) are in maraviroc?||maraviroc excipients list|
|DailyMed Link:||maraviroc at DailyMed|
Recent Clinical Trials for maraviroc
Identify potential brand extensions & 505(b)(2) entrants
|Parkwood Hospital, London, Ontario||Phase 2|
|The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation||Phase 2|
|Soroka University Medical Center||Phase 2|
Generic filers with tentative approvals for MARAVIROC
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
Pharmacology for maraviroc
|Drug Class||CCR5 Co-receptor Antagonist |
|Mechanism of Action||Chemokine Co-receptor 5 Antagonists |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Viiv Hlthcare||SELZENTRY||maraviroc||TABLET;ORAL||022128-003||Nov 4, 2016||RX||Yes||No||⤷ Try it Free||⤷ Try it Free||Y||⤷ Try it Free|
|Viiv Hlthcare||SELZENTRY||maraviroc||SOLUTION;ORAL||208984-001||Nov 4, 2016||RX||Yes||Yes||⤷ Try it Free||⤷ Try it Free||Y||⤷ Try it Free|
|Viiv Hlthcare||SELZENTRY||maraviroc||TABLET;ORAL||022128-004||Nov 4, 2016||RX||Yes||No||⤷ Try it Free||⤷ Try it Free||Y||⤷ Try it Free|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Patent No.||Patent Expiration|
|Viiv Hlthcare||SELZENTRY||maraviroc||TABLET;ORAL||022128-002||Aug 6, 2007||⤷ Try it Free||⤷ Try it Free|
|Viiv Hlthcare||SELZENTRY||maraviroc||SOLUTION;ORAL||208984-001||Nov 4, 2016||⤷ Try it Free||⤷ Try it Free|
|Viiv Hlthcare||SELZENTRY||maraviroc||TABLET;ORAL||022128-004||Nov 4, 2016||⤷ Try it Free||⤷ Try it Free|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>Patent No.||>Patent Expiration|
|Patent Number||Supplementary Protection Certificate||SPC Country||SPC Expiration||SPC Description|
|1284974||08C0007||France||⤷ Try it Free||PRODUCT NAME: MARAVIROC; REGISTRATION NO/DATE: EU/1/07/418/001 20070918|
|1284974||PA2008004||Lithuania||⤷ Try it Free||PRODUCT NAME: MARAVIROCUM; REGISTRATION NO/DATE: EU/1/07/418/001 - EU/1/07/418/010 20070918|
|1284974||SZ 6/2008||Austria||⤷ Try it Free||PRODUCT NAME: MARAVIROC, GEGEBENENFALLS IN DER FORM EINES PHARMAZEUTISCH VERTRAEGLICHEN SALZES|
|>Patent Number||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration||>SPC Description|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.